Sort
48,018 grants matching “immunotherapy”
Leadership, Planning an Evaluation
$534,647Kelvin P Lee · Indiana University Indianapolis · P30 · FY2025 · CA
Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism
$534,622Arlene H Sharpe · Harvard Medical School · R01 · FY2024 · CA
Career Development in Pediatric and Medical Oncology
$534,606Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2010 · CA
Antibody Mediated Immune Regulation
$534,598James C. Zimring · University Of Virginia · P01 · FY2020 · HL
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$534,585Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$534,470Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
ShRNAmir-RV Library Construction and Production
$534,463Matthew Eugene Pipkin · La Jolla Institute For Immunology · U19 · FY2015 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2023 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2022 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2021 · AI
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
$534,418Ginny L Bumgardner · Ohio State University · R01 · FY2020 · AI
Znf740 in the regulation of CD8+T cell exhaustion
$534,291Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2024 · CA
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$534,207John K. Wiencke · University Of California, San Francisco · P50 · FY2019 · CA
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
$534,184E. John Wherry · University Of Pennsylvania · P01 · FY2019 · CA
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
$534,184E. John Wherry · University Of Pennsylvania · P01 · FY2017 · CA
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
$534,183E. John Wherry · University Of Pennsylvania · P01 · FY2021 · CA
Project 3: Genetic and epigenetic basis of resistance to RT and ICB
$534,183E. John Wherry · University Of Pennsylvania · P01 · FY2022 · CA
Project 1
$534,168David J Odde · University Of Minnesota · P01 · FY2024 · CA
Mechanism(s) of pathogenicity for Candida auris
$534,014Jeniel E Nett · University Of Wisconsin-Madison · R01 · FY2023 · AI
Mechanism(s) of pathogenicity for Candida auris
$534,014Jeniel E Nett · University Of Wisconsin-Madison · R01 · FY2022 · AI
Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation
$533,970Scott Henry Olejniczak · Roswell Park Cancer Institute Corp · R01 · FY2021 · AI
Project 2: Role of radiation therapy in establishing cancer immunity
$533,953Andy J Minn · University Of Pennsylvania · P01 · FY2019 · CA
Project 2: Role of radiation therapy in establishing cancer immunity
$533,953Andy J Minn · University Of Pennsylvania · P01 · FY2017 · CA
Project 2: Role of radiation therapy in establishing cancer immunity
$533,953Andy J Minn · University Of Pennsylvania · P01 · FY2021 · CA
Project 2: Role of radiation therapy in establishing cancer immunity
$533,953Andy J Minn · University Of Pennsylvania · P01 · FY2022 · CA